At Maze Medical Fitness Testing (MMFT), we’re not just interested in how you look or even how you perform, we care about what’s happening beneath the surface.
Because here’s the truth:
You can have a great VO₂ max, solid muscle mass, and still miss something important.
That’s where emerging cancer screening tools like Galleri® blood testing and MRI-based screening (like Ezra) are starting to enter the conversation, not as replacements for traditional screening, but as potential additions to a proactive, data driven health strategy.
As part of Maze Health’s full spectrum approach to preventive care and longevity , we are exploring offering these options to current patients when clinically appropriate, with the same precision, context, and guidance that defines MMFT.
Why This Matters for the MMFT Patient
MMFT is built on one core idea:
You can’t optimize what you don’t measure.
We already measure:
VO₂ max (cardiovascular fitness)
Body composition (DEXA)
Bone Density (DEXA)
Metabolic rate (RMR)
Advanced bloodwork
Together, these create a complete health blueprint often uncovering risks that traditional checkups miss .
Cancer screening especially newer multi-cancer or whole body approaches is a natural extension of this philosophy:
Looking for problems before they become symptoms.
Identifying risk earlier, when intervention is easier.
Layering data for a more complete picture of health and longevity.
What is Galleri®? (The Blood Test That Looks for Multiple Cancers)
Galleri® is a multi-cancer early detection (MCED) blood test that looks for DNA patterns associated with cancer and may suggest where in the body the signal is coming from. (ACS overview referenced previously)
Why MMFT patients are interested:
It’s a simple blood draw
It aims to detect cancers without standard screening tests
It aligns with preventive, data-first health strategies
But:
It is not FDA-approved (offered as a lab developed test)
A positive result requires follow up testing
It does not replace traditional screenings (colonoscopy, mammogram, etc.)
In other words:
It’s a signal not a diagnosis.
What is MRI-Based Screening (Ezra-style)
MRI-based screening uses imaging to evaluate multiple organs often referred to as “whole-body MRI.”
Why it fits the MMFT mindset:
- No radiation exposure
- Provides visual insight across organ systems
- Can uncover hidden abnormalities
This aligns with MMFT’s mission of uncovering “silent risks” before they become major issues similar to how we detect visceral fat, metabolic inefficiencies, or early cardiovascular limitations.
The Catch (Because There Always Is One)
Even the most advanced tools come with trade offs.
For MRI screening:
- Major radiology groups say there’s not enough evidence to recommend it for average risk, symptom free individuals
- It can lead to incidental findings → more testing, more anxiety
For Galleri:
- False positives and negatives exist
- Large scale data is still evolving
- Follow up pathways need to be planned before testing
This is why these tools only make sense in the right clinical context, not as impulse add-ons.
Galleri vs. MRI: How They Fit Into a Performance & Longevity Strategy
Galleri (Blood Based Detection)
- Think: “Signal detection”
- Best for: expanding screening beyond standard tests
- Role: early alert system
MRI Screening (Imaging – Based Detection)
- Think: “Structural overview”
- Best for: visualizing organs and identifying abnormalities
- Role: deep scan of the body
MMFT Perspective:
These aren’t competing tools, they’re complementary layers of data.
Just like:
VO₂ max + DEXA + bloodwork = full performance picture
- Galleri + imaging + clincial context = more complete risk awareness
How MMFT Would Approach This (Very Differently Than the Internet)
Most of what you see online about these tests is either:
- “This will detect everything early!”
or
- “This is useless and overhyped!”
Reality lives in the middle
At MMFT, if we offer these options, it will be:
1) For current Maze patients only
Because context matters and we already understand your baseline data, goals, and risks.
2) Clinician guided
We evaluate:
- Age
- Family history
- Existing health data (including MMFT metrics)
- Risk tolerance
- Readiness for follow up testing
3) Integrated into your overall data
We don’t look at one test in isolation.
We ask:
- Does this align with your metabolic risk profile?
- Does your body composition or inflammation suggest higher concern?
- Are we solving a real clinician question or just adding noise?
The Bigger Picture: Performance Health Isn’t Just About Fitness
You can:
- Hit personal records in the gym
- Dial in your nutrition
- Optimize your hormones
…and still miss something silently developing.
That’s why MMFT exists to bring medical precision into performance and longevity.
Adding advanced cancer screening when appropriate is simply the next evolution of that model.
Who Might Consider This?
Within MMFT, this conversation may make sense for:
- Patients focused on longevity and proactive health
- Individuals with family history concerns
- Patients already optimizing
- hormones
- metabolic health
- cardiovascular fitness
- Those who want more data and understand the trade-offs
A grounded (and honest) takeaway
If traditional screening is the foundation…
And MMFT is the blueprint…
Then tools like Galleri and MRI screening are:
Optional but potentially powerful layers of insight
Not for everyone.
Not Perfect.
But when used thoughtfully part of a smarter, more proactive approach to health.
Final Thought (MMFT Style)
At MMFT, we don’t chase trends.
We evaluate tools.
If something helps us:
- detect risk earlier
- personalize care better
- or give you a clearer picture of your long term health
—we consider it.
And if it doesn’t?
We skip it.
That’s the difference between data … and useful data.
